These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34213742)

  • 1. Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis.
    Yang N; Chen Z; Zhang X; Shi Y
    BioDrugs; 2021 Jul; 35(4):401-415. PubMed ID: 34213742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis.
    Uppal SK; Kearns DG; Chat VS; Han G; Wu JJ
    J Dermatolog Treat; 2022 Mar; 33(2):626-636. PubMed ID: 32507066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.
    Ratchataswan T; Banzon TM; Thyssen JP; Weidinger S; Guttman-Yassky E; Phipatanakul W
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1053-1065. PubMed ID: 33685604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
    Werfel T
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies for atopic dermatitis: An update.
    Deleanu D; Nedelea I
    Exp Ther Med; 2019 Feb; 17(2):1061-1067. PubMed ID: 30679974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
    Chu CY
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological agents targeting interleukin-13 for atopic dermatitis.
    Chiricozzi A; Gori N; Maurelli M; Gisondi P; Caldarola G; De Simone C; Peris K; Girolomoni G
    Expert Opin Biol Ther; 2022 May; 22(5):651-659. PubMed ID: 35081849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective IL-13 inhibitors for the treatment of atopic dermatitis.
    Gonçalves F; Freitas E; Torres T
    Drugs Context; 2021; 10():. PubMed ID: 33889195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis.
    Bernardo D; Bieber T; Torres T
    Am J Clin Dermatol; 2023 Sep; 24(5):753-764. PubMed ID: 37266844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current and upcoming treatments of adult atopic dermatitis].
    Lacour JP
    Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tralokinumab for the Treatment of Atopic Dermatitis.
    Freitas E; Guttman-Yassky E; Torres T
    Am J Clin Dermatol; 2021 Sep; 22(5):625-638. PubMed ID: 34155602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Therapies for Atopic Dermatitis: A Systematic Review.
    Zhou S; Qi F; Gong Y; Zhang J; Zhu B
    Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
    Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
    Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of the IL-13 pathway in skin inflammation.
    Tubau C; Puig L
    Expert Rev Clin Immunol; 2021 Jan; 17(1):15-25. PubMed ID: 33275064
    [No Abstract]   [Full Text] [Related]  

  • 16. A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis.
    Miyano T; Irvine AD; Tanaka RJ
    Allergy; 2022 Feb; 77(2):582-594. PubMed ID: 33894014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of IL-13: A New Pathway for Atopic Dermatitis [Formula: see text].
    Ratnarajah K; Le M; Muntyanu A; Mathieu S; Nigen S; Litvinov IV; Jack CS; Netchiporouk E
    J Cutan Med Surg; 2021; 25(3):315-328. PubMed ID: 33350863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human.
    Yamamura Y; Nakashima C; Otsuka A
    Front Med (Lausanne); 2024; 11():1342176. PubMed ID: 38590314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.